nevirapine has been researched along with raltegravir in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| De Maeyer, M; Debyser, Z; Desadeleer, C; Hombrouck, A; Van Remoortel, B; Voet, A; Witvrouw, M | 1 |
| Engelman, A; Haim, H; Koh, Y | 1 |
| Ba, M; Gu, Q; Guo, Y; Li, D; Li, G; Li, L; Ma, X; Zhu, T | 1 |
| Ba, M; Cao, Y; Guo, C; Guo, Y; He, R; Li, Z; Liang, Y; Tang, C; Xu, Z; Yang, Y; Zhang, X; Zhou, H; Zhu, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altieri, A; Belov, DS; Curreli, F; Debnath, AK; Kurkin, AV; Kwon, YD; Kwong, PD; Ramesh, RR | 1 |
| Abadi, LF; Bhutani, KK; Desai, D; Gaikwad, S; Gupta, S; Kulkarni, S; Kumar, S; Singh, IP | 1 |
| Bal, C; Mitra, A; Mitra, D; Parveen, A; Rozy, F; Sharon, A; Trivedi, J | 1 |
| Kumar Kushwaha, P; Kumar, R; Kumari, N; Mitra, D; Saurabh Srivastava, K; Sharon, A | 1 |
1 review(s) available for nevirapine and raltegravir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for nevirapine and raltegravir
| Article | Year |
|---|---|
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137.
Topics: Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Naphthyridines; Quinolones; Virus Replication | 2008 |
Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity.
Topics: Adenine; Anti-HIV Agents; Cell Line; HeLa Cells; HIV-1; Humans; Integrase Inhibitors; Organophosphonates; Pyrrolidinones; Quinolones; Raltegravir Potassium; Tenofovir; Zidovudine | 2011 |
Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73.
Topics: Animals; Anti-HIV Agents; HIV-1; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polycyclic Sesquiterpenes; Porifera; Reverse Transcriptase Inhibitors; Sesquiterpenes; Spiro Compounds; Stachybotrys; Structure-Activity Relationship | 2013 |
2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.
Topics: Drug Design; Drug Resistance, Viral; HEK293 Cells; HIV Reverse Transcriptase; HIV-1; Humans; Inhibitory Concentration 50; Models, Molecular; Mutation; Protein Conformation; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Thiazoles | 2014 |
Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
Topics: Anti-HIV Agents; Biomimetic Materials; CD4 Antigens; Cell Line; Crystallography, X-Ray; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Pyrroles; Structure-Activity Relationship; Thiazoles; Virus Internalization | 2017 |
Synthesis and in-vitro anti-HIV-1 evaluation of novel pyrazolo[4,3-c]pyridin-4-one derivatives.
Topics: Anti-HIV Agents; Blood-Brain Barrier; Cell Survival; Drug Design; HeLa Cells; HIV Reverse Transcriptase; Humans; Molecular Docking Simulation; Molecular Structure; Protein Binding; Pyrazoles; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2019 |
Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity.
Topics: Acetamides; Androstenols; Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Discovery; HIV-1; HSP90 Heat-Shock Proteins; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Virus Replication | 2019 |
Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs.
Topics: Anti-HIV Agents; Cell Line; Dose-Response Relationship, Drug; HIV-1; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Virus Replication | 2022 |